Clinical Trial: A Study to Evaluate the Safety and Pharmacokinetics of AD-123 Compared to Coadministration of AD-1231 and AD-1232

U.S., April 21 -- ClinicalTrials.gov registry received information related to the study (NCT07538466) titled 'A Study to Evaluate the Safety and Pharmacokinetics of AD-123 Compared to Coadministration of AD-1231 and AD-1232' on April 12.

Brief Summary: A Study to Evaluate the Safety and Pharmacokinetics of AD-123 Compared to Coadministration of AD-1231 and AD-1232

Study Start Date: April, 2026

Study Type: INTERVENTIONAL

Condition: Diabetes Mellitus

Intervention: DRUG: AD-123

AD-123 Oral Tablet

DRUG: AD-1231 and AD-1232

AD-1231 Oral Tablet + AD-1232 Oral Tablet

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Addpharma Inc.

Published by HT Digital Content Services with permission from Health Daily Digest....